Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...

The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death.

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

Circulating tumor DNA as a prognostic biomarker for long-term survival in de-novo oligometastatic non-small cell lung cancer. The prevalence and outcomes of hypercalcemia in Black American patients ...

Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.